MTEX Form 4/A: CEO Amends Option Vesting; 20,000 Options at $10.60
Mannatech Inc. (MTEX) reporting person Fredrick Landen Granvel, President and CEO, amended a Form 4 to correct the vesting schedule for a stock option grant dated 06/03/2025.
Rhea-AI Filing Summary
Mannatech Inc. (MTEX) reporting person Fredrick Landen Granvel, President and CEO, amended a Form 4 to correct the vesting schedule for a stock option grant dated 06/03/2025. The amendment states the options (20,000 shares underlying) have a three-year vesting schedule: one-third on each anniversary of the grant, with immediate vesting upon a change in control. The options have a $10.60 exercise price and expire 06/03/2035. The report also shows a sale of 3,975 shares of common stock and a total beneficial ownership of 44,000 shares following the transactions. The amendment corrects an earlier filing that contained an incorrect vesting schedule.
Positive
- Clarified vesting schedule improves transparency by specifying one-third vesting each anniversary over three years.
- Change-in-control acceleration provides clear terms that protect executive interests and are disclosed to investors.
- Option grant details are explicit: 20,000 options at a $10.60 exercise price expiring 06/03/2035.
Negative
- Insider sale of 3,975 shares reduces the reporting person's direct holdings.
- Original Form 4 contained incorrect vesting information, requiring an amendment which may raise minor disclosure control questions.
Insights
TL;DR: CEO amended Form 4 fixing option vesting; 20,000 options granted at $10.60 with standard three-year vesting and change-in-control acceleration.
The amendment clarifies the vesting cadence for a material option grant rather than altering economics: 20,000 options exercisable through 2035 at $10.60 and vesting in three equal annual tranches. Such a schedule aligns management incentives with multi-year performance while the change-in-control acceleration provides common protection for executives. A contemporaneous sale of 3,975 shares reduces direct holdings but does not materially change total reported beneficial ownership of 44,000 shares.
TL;DR: Amendment corrects disclosure; vesting terms and change-in-control clause are explicit, improving transparency for investors.
Filing an amendment to correct vesting details improves disclosure quality and reduces ambiguity about executive compensation timing. The three-year cliff/annual tranche approach and explicit acceleration on change in control are common governance features. The record shows standard Section 16 reporting practices with a POA signature, and the corrected schedule helps investors assess potential dilution timing from option exercises.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Right to Purchase Common Stock | 20,000 | $0.00 | $0.00 |
| holding | Common Stock Par Value $0.0001 Per Share | -- | -- | -- |
Footnotes (1)
- F1. The Form 4 that was filed on 6/5/2025 was filed with the incorrect vesting schedule. The correct vesting schedule is one-third of the stock options vest on the first anniversary of the date of grant, another one-third of the stock options vest on the second anniversary of the date of grant and the remaining one-third of the stock options vest on the third anniversary of the date of grant.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What changes were made in the Form 4/A for Mannatech (MTEX)?
How many options and at what price were granted to the reporting person?
What is the reporting person's total beneficial ownership after the transactions?
Does the option vest immediately in any circumstance?
AI-generated analysis. How Rhea-AI works. Not financial advice.